logo
Empire Petroleum Reports Results for Second Quarter 2025 and Demonstrates Operational Momentum

Empire Petroleum Reports Results for Second Quarter 2025 and Demonstrates Operational Momentum

Business Wire18 hours ago
TULSA, Okla.--(BUSINESS WIRE)-- Empire Petroleum (NYSE American: EP) ('Empire' or the 'Company'), an oil and gas company with producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, today reported operational and financial results for the second quarter 2025.
SECOND QUARTER 2025 HIGHLIGHTS
Produced Q2-2025 net production volumes of 2,357 barrels of oil equivalent per day ('Boe/d'), an increase of 15% compared to Q1-2025;
Reported 1,493 barrels of oil per day ('Bbls/d');
Boe/d is comprised of 63% oil, 19% natural gas liquids ('NGLs'), and 18% natural gas;
As part of Empire's Enhanced Oil Recovery ('EOR') efforts in the Starbuck Drilling Program ('Starbuck') in North Dakota, modified wellhead installations are underway and expected to be completed in Q3-2025, with advanced fabrication work progressing toward completion by year-end;
While certain rare alloys and specialized materials for the EOR process remain in fabrication, production has continued to improve and operations are showing increased consistency;
Installation of the modified rare alloys for the EOR units is expected to be completed and fully operational in Q4-2025;
Empire expects to finalize the patented design specifications for its hydrocarbon vaporization technology by the end of Q4-2025, with the system leveraging elevated temperatures and pressure changes to enhance recovery efficiency;
Empire made significant progress in preparing for its inaugural drilling campaign in Texas, completing its first drilling pad and preparing multiple locations for entry as part of its development plan;
The Company also advanced critical pre-drill activities during Q2-2025, including surface land work, rig evaluation, and the permitting process, laying the groundwork for horizontal development across multiple prospective pay zones identified in the region;
Empire expects drilling operations to commence in Q4-2025;
Launched a subscription rights offering ('Rights Offering') with the intention to raise approximately $5.0 million in gross proceeds, including $2.5 million from the anticipated future exercise of the warrants issued as part of the Rights Offering, to provide shareholders the opportunity to increase their equity position;
Each shareholder of record as of July 10, 2025, is entitled to purchase one unit at a subscription price equal to $0.07367 per unit, each unit consisting of 0.0139 shares of the Company's common stock and one rights warrant to purchase 0.0136 shares of the Company's common stock equal to $5.46 per whole share;
Stockholders who fully exercise their subscription rights are entitled to oversubscribe for additional units, subject to availability and pro-rata allocation of units;
As stated in previous filings, Phil E. Mulacek, Chairman of the Board and one of Empire's largest shareholders, has expressed his intent to fully subscribe to the units available through his subscription rights and to fully exercise his over-subscription rights to purchase his pro-rata share of any remaining unsubscribed securities at the offering's expiration;
The Rights Offering is set to expire at 5:00 p.m., Eastern Time, on August 18, 2025, and proceeds are expected to be used for balance sheet optimization efforts and general corporate purposes;
Reported Q2-2025 total product revenue of $8.7 million, a net loss of $5.1 million, or ($0.15) per diluted share, primarily driven by lower realized commodity prices, which included a 12% decrease in realized oil prices compared to Q1-2025 and a 23% decrease compared to Q2-2024;
Despite a 15% increase in equivalent production compared to Q1-2025, the significant decline in realized commodity pricing drove lower financial results for the quarter;
Adjusted EBITDA of ($1.2) million for Q2-2025.
2025 OUTLOOK
'While commodity prices were significantly under pressure (NYMEX oil prices down ~10% from Q1-2025 and down ~20% from Q2-2024) in the second quarter due to a mix of global market condition and seasonal factors, I believe this environment is temporary,' said Phil Mulacek, Chairman of the Board. 'Reported North American data shows that the oil well rig count is at post-COVID lows, compared to 2021 levels, while the hydraulic fracturing spread count is even lower at levels not seen since late 2020 through the end of 2021. These material market indicators should result in lower production going forward. Compounding this, U.S. production has already peaked and is approximately 250,000 barrels per day lower than the high earlier in 2025. This supports my strong belief that overall pricing is trending upward over the next four to six quarters. Over the next six to nine months, we anticipate a continued rebound that could increase our production levels. Empire is strategically positioned to benefit from this upswing with focused production increases. The Empire team continues to demonstrate disciplined planning and execution, placing the Company on a stronger path to lasting growth. My decision to fully subscribe and oversubscribe in the Rights Offering reflects my strong confidence in the Company's long-term potential.'
Mike Morrisett, President and CEO, added, 'We were pleased to restore and maintain production across key assets during the second quarter, particularly in North Dakota. However, lower-than-expected commodity pricing impacted revenue and margins, offsetting our operational gains. We remain focused on executing our development plans and maintaining cost discipline as we position the Company to capitalize on a potential pricing recovery.'
North Dakota – Williston Basin:
Empire remains confident in the trajectory of its EOR program in the Starbuck region and expects to reach steady-state production levels by the end of Q4-2025, contingent on continued equipment reliability and seasonal operating stability; and
With key infrastructure milestones nearing completion and EOR operations delivering steadily improving performance, the program is expected to support sustained production growth and improved asset performance over the long term.
New Mexico – Permian Basin:
After four years of expenditures, Empire anticipates receiving a ruling from the New Mexico Oil Conservation Commission ('NMOCD') in Q3-2025, regarding its applications to revoke four existing permits and deny five new applications for what the Company believes is the illegal disposal of wastewater into Eunice Monument South Unit's ('EMSU') Unitized Interval by the largest of the third-party Saltwater Disposal ('SWD') operators;
Pending the NMOCD's decision, Empire plans to proceed with Motions to Revoke the existing permits granted to the remaining three SWD Companies disposing wastewater into the EMSU and Arrowhead Grayburg Unit ('AGU') Unitized Interval, while concurrently advancing litigation for trespass and damages;
While litigation has limited the scope of development activity in the affected areas, production from the EMSU and AGU units has increased in recent months, reflecting ongoing optimization efforts; and
The Company expects final resolution of this matter to result in a meaningful reduction in operating expenses and contribute to improved financial performance going forward.
Texas – East Texas Basin:
Empire remains on track to initiate drilling operations in Q4-2025, as part of its broader development strategy in the region;
The upcoming program is designed to target multiple prospective pay zones identified during technical evaluation, with a focus on horizontal development opportunities that support long-term, capital-efficient production;
The Company expects this activity to establish a foundation for scalable development throughout 2026 and beyond;
As of the first week of August 2025, the first drilling pad has been completed, and the Company is actively securing materials, equipment, rigs, and other necessary resources to begin and conclude drilling operations on the initial wells in Q4-2025; and
The production targets associated with these wells are expected to deliver the most significant impact to Empire's portfolio to date.
SECOND QUARTER 2025 FINANCIAL AND OPERATIONAL RESULTS
Net sales volumes for Q2-2025 were 2,357 Boe/d, including 1,493 barrels of oil per day; 430 barrels of NGLs per day, and 2,606 thousand cubic feet per day ('Mcf/d') or 434 Boe/d of natural gas. Oil sales volumes decreased approximately 15% compared to Q2-2024 primarily due to redrilling efforts in North Dakota and natural decline.
Empire reported Q2-2025 total product revenue of $8.7 million versus $12.8 million in Q2-2024. Contributing to the decrease were lower oil sales volumes and lower realized oil and NGL prices. Realized oil and natural gas liquids prices decreased 23% and 14%, respectively, due to a general decline in overall market pricing.
Lease operating expenses in Q2-2025 decreased to $6.4 million versus $7.5 million in Q2-2024 primarily due to lower workover costs. Q2-2025 workover expense decreased to $0.5 million versus $1.6 million in Q2-2024. Higher workover expense in 2024 was primarily in New Mexico as Empire continued work in the region to enhance and maintain production.
Production and ad valorem taxes for Q2-2025 were $0.8 million versus $1.1 million in Q2-2024, as a result of lower product revenues.
Depreciation, Depletion, and Amortization ('DD&A') and Accretion for Q2-2025 was $3.1 million versus $3.2 million for Q2-2024. The decrease in DD&A is primarily due to lower production volumes partially offset by the acquisition of additional working interest in New Mexico and the impact of the capitalized costs associated with the new drilling as part of Empire's Starbuck Drilling Program in North Dakota. Accretion increased slightly due to the new drilling activity and acquisition of working interest in New Mexico.
General and administrative expenses, excluding share-based compensation expense, was $2.9 million, or $13.55 per Boe in Q1-2025 versus $2.4 million, or $9.80 per Boe in Q2-2024. The increase in expenses was primarily due to an increase in salaries and benefits associated with an increase in employee headcount.
Interest expense for Q2-2025 slightly decreased, compared to Q2-2024, primarily due to certain non-cash interest expense in Q2-2024 from the convertible promissory note partially offset by a higher average outstanding balance on the Company's credit facility.
Empire recorded a net loss of $5.1 million in Q2-2025, or ($0.15) per diluted share, versus a Q2-2024 net loss of $4.4 million, or ($0.15) per diluted share.
Adjusted EBITDA was ($1.2) million for Q2-2025 compared to Adjusted EBITDA of $1.7 million in Q2-2024.
CAPITAL SPENDING, BALANCE SHEET & LIQUIDITY
For the six months ended June 30, 2025, Empire invested approximately $3.3 million in total capital expenditures, primarily from finalizing drilling and completions activity related to the Starbuck Drilling Program in North Dakota and continued return-to-production efforts in Texas.
As of June 30, 2025, Empire had approximately $2.3 million in cash on hand and approximately $4.0 million available on its credit facility. Empire is scheduled to complete a subscriptions rights offering in August 2025, which is expected to raise approximately $5.0 million of gross proceeds.
UPDATED PRESENTATION
An updated Company presentation will be posted to the Company's website under the Investor Relations section.
ABOUT EMPIRE PETROLEUM
Empire Petroleum Corporation is a publicly traded, Tulsa-based oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana. Management is focused on organic growth and targeted acquisitions of proved developed assets with synergies with their existing portfolio of wells. More information about Empire can be found at www.empirepetroleumcorp.com.
SAFE HARBOR STATEMENT
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements involve a wide variety of risks and uncertainties, and include, without limitations, statements with respect to the Company's estimates, strategy, and prospects. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2024, and its other filings with the SEC. Readers and investors are cautioned that the Company's actual results may differ materially from those described in the forward-looking statements due to a number of factors, including, but not limited to, future commodity prices, the Company's ability to acquire productive oil and/or gas properties or to successfully drill and complete oil and/or gas wells on such properties, general economic conditions both domestically and abroad, including inflation, tariffs and interest rates, uncertainties associated with legal and regulatory matters, successful completion of the Rights Offering, including future exercise of the warrants issued as part of the Rights Offering, and other risks and uncertainties related to the conduct of business by the Company. Other than as required by applicable securities laws, the Company does not assume a duty to update these forward-looking statements, whether as a result of new information, subsequent events or circumstances, changes in expectations, or otherwise.
EMPIRE PETROLEUM CORPORATION
Condensed Operating Data
(Unaudited)
Three Months Ended Six Months Ended
June 30, March 31, June 30, June 30,
2025
2025
2024
2025
2024
Net Sales Volumes:
Oil (Bbl)
135,854
119,635
160,283
255,489
291,043
Natural gas (Mcf)
237,133
199,868
241,242
437,001
453,063
Natural gas liquids (Bbl)
39,091
31,453
39,612
70,544
74,397
Total (Boe)
214,467
184,400
240,102
398,867
440,951
Average daily equivalent sales (Boe/d)
2,357
2,049
2,638
2,204
2,423
Average Price per Unit:
Oil ($/Bbl)
$
58.92
$
67.28
$
76.66
$
62.84
$
74.66
Natural gas ($/Mcf)
$
0.93
$
2.74
$
(0.48
)
$
1.76
$
0.58
Natural gas liquids ($/Bbl)
$
13.33
$
12.56
$
15.58
$
12.98
$
13.89
Total ($/Boe)
$
40.78
$
48.76
$
53.26
$
44.47
$
52.21
Operating Costs and Expenses per Boe:
Lease operating expense
$
29.78
$
31.27
$
31.42
$
30.47
$
33.86
Production and ad valorem taxes
$
3.58
$
3.86
$
4.44
$
3.71
$
4.31
Depreciation, depletion, amortization and accretion
$
14.50
$
14.92
$
13.20
$
14.70
$
11.67
General & administrative expense:
General & administrative expense (excluding stock-based compensation)
$
13.55
$
17.34
$
9.80
$
15.30
$
11.87
Stock-based compensation
$
2.27
$
2.88
$
2.47
$
2.55
$
2.95
Total general & administrative expense
$
15.82
$
20.22
$
12.27
$
17.85
$
14.82
Expand
EMPIRE PETROLEUM CORPORATION
Condensed Consolidated Balance Sheets
(in thousands, except share data)
(Unaudited)
June 30, December 31,
2025
2024
ASSETS
Current Assets:
Cash
$
2,293
$
2,251
Accounts Receivable
10,167
8,155
Inventory
1,303
1,305
Prepaids
756
640
Total Current Assets
14,519
12,351
Property and Equipment:
Oil and Natural Gas Properties, Successful Efforts
144,008
140,675
Less: Accumulated Depletion, Amortization and Impairment
(36,583
)
(31,974
)
Total Oil and Gas Properties, Net
107,425
108,701
Other Property and Equipment, Net
1,484
1,391
Total Property and Equipment, Net
108,909
110,092
Other Noncurrent Assets
1,231
1,425
TOTAL ASSETS
$
124,659
$
123,868
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts Payable
$
11,935
$
10,452
Accrued Expenses
11,402
10,348
Current Portion of Lease Liability
300
400
Current Portion of Note Payable - Related Party
2,000
-
Current Portion of Long-Term Debt
530
70
Total Current Liabilities
26,167
21,270
Long-Term Debt
14,627
11,266
Long-Term Lease Liability
39
144
Asset Retirement Obligations
29,321
28,423
Total Liabilities
70,154
61,103
Stockholders' Equity:
Series A Preferred Stock - $0.001 Par Value, 10,000,000 Shares Authorized, 6 and 6 Shares Issued and Outstanding, Respectively
-
-
Common Stock - $0.001 Par Value, 190,000,000 Shares Authorized, 33,756,595 and 33,667,132 Shares Issued and Outstanding, Respectively
93
93
Additional Paid-in-Capital
144,506
143,489
Total Stockholders' Equity
54,505
62,765
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$
124,659
$
123,868
Expand
EMPIRE PETROLEUM CORPORATION
Condensed Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
Three Months Ended Six Months Ended
June 30, March 31, June 30, June 30,
2025
2025
2024
2025
2024
Cash Flows from Operating Activities:
Net Loss
$
(5,056
)
$
(4,221
)
$
(4,390
)
(9,277
)
$
(8,364
)
Adjustments to Reconcile Net Loss to Net Cash
(Used In) Provided By Operating Activities:
Stock-Based Compensation
486
531
592
1,017
1,302
Amortization of Right-of-Use Assets
120
121
136
241
271
Depreciation, Depletion and Amortization
2,576
2,226
2,677
4,802
4,167
Accretion of Asset Retirement Obligations
534
526
492
1,060
977
Loss on Commodity Derivatives
-
-
1
-
859
Settlement on or Purchases of Derivative Instruments
-
-
(253
)
-
(263
)
Loss on Financial Derivatives
-
-
1,736
-
998
Amortization of Debt Discount on Convertible Notes
-
-
500
-
500
Gain on Extinguishment of Debt
-
-
(17
)
-
(17
)
Gain on Sale of Oil and Natural Gas Properties
(175
)
-
-
(175
)
-
Gain on Sale of Other Fixed Assets
-
(32
)
-
(32
)
-
Change in Operating Assets and Liabilities:
Accounts Receivable
(2,291
)
279
(1,694
)
(2,012
)
(630
)
Inventory, Oil in Tanks
200
(199
)
346
1
(18
)
Prepaids, Current
331
94
463
425
460
Accounts Payable
(355
)
1,676
(2,484
)
1,321
1,855
Accrued Expenses
455
599
668
1,054
1,030
Other Long Term Assets and Liabilities
37
13
(574
)
50
(1,021
)
Net Cash (Used In) Provided By Operating Activities
(3,138
)
1,613
(1,801
)
(1,525
)
2,106
Cash Flows from Investing Activities:
Disposal of Oil and Natural Gas Properties
175
-
-
175
-
Additions to Oil and Natural Gas Properties
(491
)
(2,680
)
(13,202
)
(3,171
)
(30,143
)
Disposal of Other Fixed Assets
-
49
-
49
-
Purchase of Other Fixed Assets
(23
)
(18
)
(89
)
(41
)
(120
)
Cash Paid for Right-of-Use Assets
(111
)
(113
)
(125
)
(224
)
(251
)
Net Cash Used In Investing Activities
(450
)
(2,762
)
(13,416
)
(3,212
)
(30,514
)
Cash Flows from Financing Activities:
Borrowings on Credit Facility
3,000
-
-
3,000
3,950
Proceeds from Promissory Note - Related Party
2,000
-
-
2,000
5,000
Proceeds from Rights Offering, net of transaction costs
-
-
20,512
-
20,512
Principal Payments of Debt
(200
)
(21
)
(157
)
(221
)
(218
)
Net Proceeds from Warrant Exercise
-
-
629
-
629
Net Cash Provided By (Used In) Financing Activities
4,800
(21
)
20,984
4,779
29,873
Net Change in Cash
1,212
(1,170
)
5,767
42
1,465
Cash - Beginning of Period
1,081
2,251
3,491
2,251
7,793
Expand
Empire Petroleum Corporation
Non-GAAP Information
Certain financial information included in Empire's financial results are not measures of financial performance recognized by accounting principles generally accepted in the United States, or GAAP. These non-GAAP financial measures include 'Adjusted Net Loss', 'EBITDA' and 'Adjusted EBITDA'. These disclosures may not be viewed as a substitute for results determined in accordance with GAAP and are not necessarily comparable to non-GAAP performance measures which may be reported by other companies. Adjusted net loss is presented because the timing and amount of these items cannot be reasonably estimated and affect the comparability of operating results from period to period, and current periods to prior periods.
The Company defines adjusted EBITDA as net loss plus net interest expense, DD&A, accretion, amortization of right of use assets, income tax provision (benefit), and other adjustments. Company management believes this presentation is relevant and useful because it helps investors understand Empire's operating performance and makes it easier to compare its results with those of other companies that have different financing, capital and tax structures. Adjusted EBITDA should not be considered in isolation from or as a substitute for net income (loss), as an indication of operating performance or cash flows from operating activities or as a measure of liquidity. In addition, adjusted EBITDA does not represent funds available for discretionary use.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tariffs Take A Bite Out Of Deere Profit, Demand Challenges Hit Core Businesses (UPDATED)
Tariffs Take A Bite Out Of Deere Profit, Demand Challenges Hit Core Businesses (UPDATED)

Yahoo

time17 minutes ago

  • Yahoo

Tariffs Take A Bite Out Of Deere Profit, Demand Challenges Hit Core Businesses (UPDATED)

Deere & Company (NYSE:DE) shares tumbled Thursday after the agricultural equipment giant posted mixed third-quarter results and trimmed its full-year profit forecast, highlighting persistent headwinds from declining sales, tariffs, and cautious customer demand. The heavy machinery maker reported earnings per share of $4.75, beating the consensus of $4.67. It reported a 9% decline in quarterly sales to $12.02 billion, beating the consensus of $10.31 billion. Production and precision agriculture sales decreased 16% for the quarter to $4.27 billion as a result of lower shipment volumes and unfavorable price realization. Operating profit slumped 50% to $580 million primarily due to lower shipment volumes / sales agriculture and turf sales decreased 1% to $3.03 billion due to lower shipment volumes, partially offset by favorable currency translation and price realization. Operating profit decreased 2% to $485 million due to higher tariffs, partially offset by reductions in warranty expenses and lower production costs. The decreased production costs were primarily the result of lower material costs. Construction and forestry sales decreased 5% to $3.06 billion due to unfavorable price realization. Operating profit decreased 47% to $237 million primarily due to unfavorable price realization and higher production costs caused by higher tariffs, partially offset by a favorable product mix. 'By proactively managing inventory, we've matched production to retail demand, enabling our company and dealers to respond swiftly to market shifts and customer needs,' said John May, chairman and CEO of John Deere. 'By continuing to address the high levels of used equipment in the industry, we're building a healthier market for everyone, our customers, our dealers, and our business, even in these challenging times,' May added. View more earnings on DE Deere's financial services reported a net income increasing 34% to $205 million, driven by a lower provision for credit losses. Outlook Deere narrowed its fiscal 2025 net income guidance to between $4.75 billion and $5.25 billion, compared to its previous forecast of $4.75 billion to $5.50 billion, citing that customers remain cautious amid ongoing uncertainty. 'We remain committed to delivering solutions that address our customers' current needs while also laying the groundwork for future growth. For example, the increasing utilization and proven in-field effectiveness of advanced technologies, such as See & Spray and Harvest Settings Automation, are empowering customers to improve their productivity and better navigate industry challenges,' May noted. 'The positive outcomes we're enabling reinforce our confidence in Deere's future despite near-term uncertainty.' For fiscal 2025, Deere expects production and precision agriculture sales to decline between 15% and 20%, with small agriculture and turf revenues to fall by around 10% and construction and forestry sales to decline by 10%-15%. During the earnings conference call, Deere executives reportedly said tariff costs during the third quarter were about $200 million, with the pre-tariff impact forecast for 2025 now approaching $600 million. They also noted more uncertainty in the North American agricultural market and confirmed the company will continue to run factories lean to match demand. When looking at the industry, for fiscal 2025, Deere expects the U.S. and Canada large agriculture equipment sales to decline approximately 30%, while small agriculture and turf equipment sales are projected to decrease around 10%. The company sees U.S. and Canada construction equipment sales to fall by around 10%. Price Action: DE stock is trading lower by 6.49% to $480.22 at last check Thursday. Read Next:Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? DEERE (DE): Free Stock Analysis Report This article Tariffs Take A Bite Out Of Deere Profit, Demand Challenges Hit Core Businesses (UPDATED) originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

LeafWorks Expands Botanical Species ID Testing to Cover the Top 75 Herbs and Fungi for Natural Products and Foods
LeafWorks Expands Botanical Species ID Testing to Cover the Top 75 Herbs and Fungi for Natural Products and Foods

Business Wire

time18 minutes ago

  • Business Wire

LeafWorks Expands Botanical Species ID Testing to Cover the Top 75 Herbs and Fungi for Natural Products and Foods

SEBASTOPOL, Calif.--(BUSINESS WIRE)-- LeafWorks, a trailblazing botanical genomics and testing company for natural products, today announced the expansion of its DNA-based species identification services to include the most widely used herbs and fungi in natural products and foods, and their common adulterants. 'The natural products industry has long faced significant gaps in robust identification testing for challenging herbs and complex formulations. Our genetic approach fills those gaps,' - Kerin Law, Ph.D., LeafWorks Chief Scientific Officer Share In an industry where DNA testing options are lacking yet identification problems persist, this is a significant leap forward in botanical identification capabilities. The new DNA testing options give product manufacturers and sourcing managers an accurate, scalable way to confirm botanical identity—whether validating a single species or identifying multiple plant and fungal components in complex formulations. The expanded Botanical ID Testing service now offers two formats of species identification: LeafWorks® Botanical DNA ID Tests —Confirms whether a sample contains a specific species, answering the question, 'Is this the species I think it is?' LeafWorks® Adulteration DNA ID Testing —Detects common adulterants or substitutions used in natural products which can escape visual or chemistry-based detection. These are also species commonly used in many food products such as peanut, rice and wheat. These tests focus on providing reliable and robust ID testing options for the top 75 herbs and fungi in natural products, as well as common and product-specific adulterants, to solve a comprehensive scope of identification needs. Validated against a global genomic library with thousands of authenticated Botanical Reference and Certified Reference Materials—including common lookalikes, closely related sister species and adulterants—these sequencing-based tests meet 21 CFR Part 111 requirements for third-party identity verification and support full supply chain traceability. Adulteration is common in the global botanical trade, whether intentional or a byproduct of complex supply chains, such as mistaken identity. LeafWorks' DNA-based testing helps manufacturers safeguard product integrity, make informed sourcing decisions, ensure label accuracy, reduce regulatory risk, and maintain compliance. 'The natural products industry has long faced significant gaps in robust identification testing for challenging herbs and complex formulations. Our genetic approach fills those gaps,' said Kerin Law, Ph.D., LeafWorks' Chief Scientific Officer. 'DNA cannot be masked or changed. If it's present, even at trace levels, we will find it and accurately identify it using our industry-leading genomic database that took years to build with thousands of reference materials. Our clients need reliable answers, and this testing delivers exactly that.' Unlike other methods such as microscopy or macroscopy—which struggle to identify ingredients in highly processed or derived materials—or chemistry-based tests, which can miss ingredients with overlapping profiles or masked compounds, DNA analysis targets the underlying genetic code itself. As a stable, discrete material, DNA remains unaffected by cultivation conditions or the bringing together of multiple ingredients. Challenges in current identification methods are especially acute for blended products with multiple species where misidentification risk is higher — yet this is where DNA testing excels. 'DNA is built for testing identity. Development of orthogonal DNA-based identification methods that look at entire genomes and move beyond problematic barcodes or marker types will add a depth of certainty currently lacking in many species,' said LeafWorks CEO Eleanor Kuntz, Ph.D. LeafWorks' advantage goes beyond its industry-leading DNA database. By focusing on areas of the genome that are unique to each species, the company ensures the highest accuracy. Its substantial investment in a proprietary database and advanced bioinformatics pipeline enables rapid identification of these species-specific markers across thousands of samples at once, delivering unmatched precision in species identification. By integrating genomic science into routine quality control workflows, LeafWorks provides manufacturers with actionable data that supports both regulatory compliance and consumer trust. These tests help quality-assurance and quality-control teams verify ingredient identity, guide product development, assess purity, and give sourcing managers the confidence to purchase large global shipments knowing they have the correct material. 'Having reliable testing options is critical for satisfying label requirements such as 21 CFR 111, and designing a robust test takes careful genomic R&D,' added Laura Klein, Ph.D., Director of Herbal Research. 'We're proud to expand our testing to cover the top herbs and fungi used across the natural products industry, backed by rigorous methodology.' LeafWorks' Botanical ID Testing is immediately available to customers in the dietary supplements, herbal medicine, foods, cosmetics, and natural products across a diverse array of product types. For more information or to inquire about testing, visit or contact info@ About LeafWorks LeafWorks Inc. is a botanical genomics company conducting cutting-edge research and developing commercial DNA testing services for natural products. Co-founded by CEO Eleanor Kuntz, Ph.D., and CSO Kerin Law, Ph.D., the company combines scientific rigor with uncompromising ethics, specializing in DNA identification—from species ID down to trait detection—to protect and empower business operators. The company provides the necessary testing and services that help cultivators preserve their genetic IP, improve efficiency and ultimately evolve their operations. Learn more about LeafWorks Inc. at and connect on Facebook, Instagram, X and LinkedIn.

CILA Therapeutics Awarded NCATS Grant to Advance a Transformational Platform That Significantly Enhances Inhaled Delivery of RNA-LNP Into Lung Cells
CILA Therapeutics Awarded NCATS Grant to Advance a Transformational Platform That Significantly Enhances Inhaled Delivery of RNA-LNP Into Lung Cells

Business Wire

time18 minutes ago

  • Business Wire

CILA Therapeutics Awarded NCATS Grant to Advance a Transformational Platform That Significantly Enhances Inhaled Delivery of RNA-LNP Into Lung Cells

BOSTON--(BUSINESS WIRE)-- CILA Therapeutics has been awarded a competitive grant from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to advance the development of its proprietary CIL-Key™ platform — a novel, gene-agnostic delivery technology that significantly and reproducibly enhances the transfection efficiency and delivery of inhaled RNA-loaded lipid nanoparticles (RNA-LNPs) into lung epithelial cells. 'This milestone provides strong validation of CILA's scientific approach and vision to deliver practical, scalable and patient-centric solutions for some of the most formidable challenges in pulmonary medicine," said Safia Rizvi, CEO, CILA Therapeutics Share In preclinical studies, the CIL-Key™ platform (also referred to as CIL-0X in the grant) achieved up to a 430% increase in delivery of functionally intact RNA into human bronchial epithelial cells cultured at an air-liquid interface (ALI), demonstrating utility across multiple RNA-LNP formulations. 'This milestone provides strong validation of CILA's scientific approach and vision to deliver practical, scalable and patient-centric solutions for some of the most formidable challenges in pulmonary medicine,' said Safia Rizvi, CEO of CILA Therapeutics. CIL-Key™ is designed to enable efficient, localized intracellular delivery of RNA-based modalities while minimizing systemic exposure. The platform could offer significant advantages for companies developing inhaled RNA therapies and vaccines for a broad range of lung diseases, including Primary Ciliary Dyskinesia (PCD), Cystic Fibrosis (CF), COPD and Pulmonary Fibrosis, as well as respiratory infections including influenza, RSV and COVID-19. Chronic pulmonary diseases affect more than 34 million people in the U.S. and more than 545 million globally. These often progressive, life-limiting conditions have a significant impact on quality of life and a high economic burden, creating an urgent demand for novel, effective and easy-to-administer treatments like those powered by CIL-Key™. About CILA Therapeutics CILA Therapeutics is a biotechnology company focused on improving lung health through transformative, scalable, accessible therapies and technologies that easily integrate into patients' daily lives. Its vision is to empower people with pulmonary diseases to breathe easily and live fully. CILA's pipeline includes first-in-class inhaled therapeutics and CIL-Key™, a proprietary platform to enhance delivery of RNA-based therapeutics and vaccines targeting a wide spectrum of pulmonary diseases. Visit CILA is actively seeking strategic partnerships to expand the platform's application across diverse RNA-based pipelines for rare and common pulmonary indications.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store